Muscat Insurance Company SAOG (MSM:MCTI)
Oman · Delayed Price · Currency is OMR 0.7860
0.00 (0.00%)
At close: Aug 4, 2025
Sage Therapeutics Income Statement
Financials in millions OMR. Fiscal year is January - December.
Millions OMR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 3.23 | 4.89 | 4.98 | 3.27 | 4.51 | 6.26 | Upgrade |
Total Interest & Dividend Income | 1.49 | 1.65 | 1.22 | 1.13 | 1.08 | 1.39 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 1.39 | 0.49 | -0.75 | Upgrade |
Other Revenue | - | - | - | - | 0.98 | 1.2 | Upgrade |
| 4.72 | 6.53 | 6.2 | 5.79 | 7.06 | 8.1 | Upgrade | |
Revenue Growth (YoY) | -36.69% | 5.45% | 7.02% | -18.01% | -12.84% | -14.46% | Upgrade |
Policy Benefits | 3.71 | 5.87 | 5.97 | 3.56 | 2.69 | 3.95 | Upgrade |
Policy Acquisition & Underwriting Costs | - | - | - | - | 0.25 | 0.2 | Upgrade |
Depreciation & Amortization | - | - | - | - | - | 0.65 | Upgrade |
Selling, General & Administrative | -0.02 | -0.02 | - | - | 1.43 | 0.53 | Upgrade |
Provision for Bad Debts | - | - | - | - | - | 0.11 | Upgrade |
Other Operating Expenses | 0.46 | 0.43 | 0.75 | 1.11 | - | - | Upgrade |
Total Operating Expenses | 4.15 | 6.28 | 6.72 | 4.67 | 6.14 | 7.44 | Upgrade |
Operating Income | 0.56 | 0.25 | -0.53 | 1.12 | 0.92 | 0.66 | Upgrade |
Interest Expense | - | - | - | - | -0.08 | -0.04 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | 0.01 | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.02 | Upgrade |
EBT Excluding Unusual Items | 0.56 | 0.25 | -0.53 | 1.12 | 0.84 | 0.62 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0 | Upgrade |
Asset Writedown | - | - | - | - | - | -0.16 | Upgrade |
Pretax Income | 0.56 | 0.25 | -0.53 | 1.12 | 0.84 | 0.47 | Upgrade |
Income Tax Expense | -0.12 | -0.12 | -0.06 | 0.27 | 0.07 | 0.11 | Upgrade |
Net Income | 0.68 | 0.37 | -0.47 | 0.85 | 0.77 | 0.35 | Upgrade |
Net Income to Common | 0.68 | 0.37 | -0.47 | 0.85 | 0.77 | 0.35 | Upgrade |
Net Income Growth | 4165.02% | - | - | 9.85% | 118.54% | - | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 | Upgrade |
Shares Change (YoY) | - | 2.12% | -1.02% | - | - | - | Upgrade |
EPS (Basic) | 0.06 | 0.03 | -0.04 | 0.08 | 0.07 | 0.03 | Upgrade |
EPS (Diluted) | 0.06 | 0.03 | -0.04 | 0.08 | 0.07 | 0.03 | Upgrade |
EPS Growth | 4167.38% | - | - | 9.85% | 118.54% | - | Upgrade |
Free Cash Flow | - | -3.27 | 1.79 | -0.96 | -2.67 | -5.38 | Upgrade |
Free Cash Flow Per Share | - | -0.29 | 0.16 | -0.09 | -0.24 | -0.49 | Upgrade |
Operating Margin | 11.93% | 3.87% | -8.51% | 19.29% | 13.00% | 8.14% | Upgrade |
Profit Margin | 14.37% | 5.63% | -7.57% | 14.62% | 10.91% | 4.35% | Upgrade |
Free Cash Flow Margin | - | -50.04% | 28.97% | -16.57% | -37.82% | -66.46% | Upgrade |
EBITDA | 1.08 | 0.78 | 0.02 | 1.61 | 1.45 | 1.19 | Upgrade |
EBITDA Margin | 22.94% | 12.01% | 0.40% | 27.82% | 20.59% | 14.68% | Upgrade |
D&A For EBITDA | 0.52 | 0.53 | 0.55 | 0.49 | 0.54 | 0.53 | Upgrade |
EBIT | 0.56 | 0.25 | -0.53 | 1.12 | 0.92 | 0.66 | Upgrade |
EBIT Margin | 11.93% | 3.87% | -8.51% | 19.29% | 13.00% | 8.14% | Upgrade |
Effective Tax Rate | - | - | - | 24.20% | 8.68% | 24.44% | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.